Arvinas, Inc. (ARVN)

NASDAQ: ARVN · Real-Time Price · USD

11.83

+0.66 (5.91%)

At close: Jan 6, 2026, 4:00 PM EST

11.67

-0.16 (-1.35%)

After-hours: Jan 6, 2026, 6:50 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
Protein Degradation Therapies	263.40M	Log In	Log In	Log In	Log In	Upgrade
Protein Degradation Therapies Growth	235.54%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
United States	263.40M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	235.54%	Log In	Log In	Log In	Log In	Upgrade